Kathryn J Collier

CIK 1737436 · last filed 2025-06-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

1

Total Filings

17

Lifetime Open-Market Net

$17.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Regulus Therapeutics Inc. (RGLS) Delisted	Director	0	$8.16	$0	$17.3K	17	2025-06-27

Recent Filings · Page 2 of 2

17 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2020-06-19	Regulus Therapeutics Inc. (RGLS) Delisted	Grant (A)	—	$0	EDGAR
2019-10-15	Regulus Therapeutics Inc. (RGLS) Delisted	Grant (A)	—	$0	EDGAR
2018-11-19	Regulus Therapeutics Inc. (RGLS) Delisted	Buy (P)	+7,100	$10.0K	EDGAR
2018-11-13	Regulus Therapeutics Inc. (RGLS) Delisted	Mixed	+16,874	$0	EDGAR
2018-06-05	Regulus Therapeutics Inc. (RGLS) Delisted	Grant (A)	+7,695	$5.7K	EDGAR
2018-05-21	Regulus Therapeutics Inc. (RGLS) Delisted	Grant (A)	—	$0	EDGAR
2018-04-17	Regulus Therapeutics Inc. (RGLS) Delisted	Grant (A)	+60,234	$38.5K	EDGAR

Showing 11–17 of 17

Prev Page 2 of 2

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.